Olivia A. Perng, et.al., The degree of CD4+ T cell autoreactivity determines cellular pathways underlying inflammatory arthritis., Journal of immunology (Baltimore, Md. : 1950), 2014, 192

http://rdf.ncbi.nlm.nih.gov/pubmed/24591372

Olivia A. Perng, et.al., The degree of CD4+ T cell autoreactivity determines cellular pathways underlying inflammatory arthritis., Journal of immunology (Baltimore, Md. : 1950), 2014, 192

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• heart inflammation_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0001853CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• arthritis_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0002993CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• abnormal lymph node morphology_Igk<tm1Dhu>/Igk<tm1Dhu>,Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0002339CCgIgktm1DhuTgH2EaHAAjcaTgTcraTcrbAjcaIgktm1DhuIgktm1DhuTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaIgktm1DhuTgTcraTcrbAjca
• kidney inflammation_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0001859CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• abnormal CD4-positive, alpha beta T cell morphology_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0002432CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• abnormal lung morphology_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0001175CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• abnormal articular cartilage morphology_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0006433CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• joint inflammation_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0002933CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• abnormal CD4-positive, alpha-beta T cell physiology_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0005463CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• abnormal circulating cytokine level_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0010210CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• increased circulating interleukin-17 level_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0008614CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• abnormal circulating cytokine level_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0010210CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• joint inflammation_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0002933CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• decreased circulating interleukin-6 level_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0008597CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• abnormal CD4-positive, alpha beta T cell morphology_Igk<tm1Dhu>/Igk<tm1Dhu>,Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0002432CCgIgktm1DhuTgH2EaHAAjcaTgTcraTcrbAjcaIgktm1DhuIgktm1DhuTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaIgktm1DhuTgTcraTcrbAjca
• abnormal CD4-positive, alpha beta T cell morphology_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0002432CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• abnormal articular cartilage morphology_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0006433CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• arthritis_Igk<tm1Dhu>/Igk<tm1Dhu>,Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0002993CCgIgktm1DhuTgH2EaHAAjcaTgTcraTcrb1VboIgktm1DhuIgktm1DhuTgH2EaHAAjca0TgTcraTcrb1Vbo0Igktm1DhuTgH2EaHAAjcaTgTcraTcrb1Vbo
• increased IgG level_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0002493CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• arthritis_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0002993CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• increased circulating interleukin-6 level_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)1Vbo/0
  http://metadb.riken.jp/0008596CCgTgH2EaHAAjcaTgTcraTcrb1VboTgH2EaHAAjca0TgTcraTcrb1Vbo0TgH2EaHAAjcaTgTcraTcrb1Vbo
• abnormal spleen morphology_Igk<tm1Dhu>/Igk<tm1Dhu>,Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0000689CCgIgktm1DhuTgH2EaHAAjcaTgTcraTcrbAjcaIgktm1DhuIgktm1DhuTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaIgktm1DhuTgTcraTcrbAjca
• increased IgG level_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0002493CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• enlarged lymph nodes_Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0000702CCgTgH2EaHAAjcaTgTcraTcrbAjcaTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaTgTcraTcrbAjca
• decreased susceptibility to autoimmune disorder_Igk<tm1Dhu>/Igk<tm1Dhu>,Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0005351CCgIgktm1DhuTgH2EaHAAjcaTgTcraTcrbAjcaIgktm1DhuIgktm1DhuTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaIgktm1DhuTgTcraTcrbAjca
• increased CD4-positive, alpha beta T cell number_Igk<tm1Dhu>/Igk<tm1Dhu>,Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0008074CCgIgktm1DhuTgH2EaHAAjcaTgTcraTcrbAjcaIgktm1DhuIgktm1DhuTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaIgktm1DhuTgTcraTcrbAjca
• absent B cells_Igk<tm1Dhu>/Igk<tm1Dhu>,Tg(H2-Ea-HA)#Ajca/0,Tg(Tcra/Tcrb)#Ajca/0
  http://metadb.riken.jp/0008071CCgIgktm1DhuTgH2EaHAAjcaTgTcraTcrbAjcaIgktm1DhuIgktm1DhuTgH2EaHAAjca0TgTcraTcrbAjca0TgH2EaHAAjcaIgktm1DhuTgTcraTcrbAjca